Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway. [electronic resource]
Producer: 19990813Description: 4313-25 p. digitalISSN:- 0950-9232
- 3T3 Cells
- Acetylcysteine -- analogs & derivatives
- Animals
- CDC2-CDC28 Kinases
- Cyclin-Dependent Kinase 2
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclin-Dependent Kinases -- immunology
- Cyclins -- genetics
- Cycloheximide -- pharmacology
- Cysteine Endopeptidases -- metabolism
- Cysteine Proteinase Inhibitors -- pharmacology
- Gene Deletion
- Gene Expression Regulation, Neoplastic
- Growth Inhibitors
- Hemagglutinins -- immunology
- Humans
- Leupeptins -- pharmacology
- Mice
- Models, Genetic
- Multienzyme Complexes -- metabolism
- Mutagenesis
- Osteosarcoma -- metabolism
- Proliferating Cell Nuclear Antigen -- metabolism
- Proteasome Endopeptidase Complex
- Protein Serine-Threonine Kinases -- immunology
- Protein Synthesis Inhibitors -- pharmacology
- Time Factors
- Transfection
- Tumor Cells, Cultured
- Ubiquitins -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.